Abstract | BACKGROUND: METHODS: RESULTS: The basal values and those of the three 10-day subsequent 100-, 250-, and 500-mg(kg.d) cholestyramine periods were as follows: total cholesterol: 327.6 +/- 77.1, 305.4 +/- 52.1, 290.6 +/- 24.1, and 320.6 +/- 32.3, respectively (P = 0.668); triglyceride: 136.4 +/- 14.6, 144.8 +/- 41.3, 161 +/- 30.9, and 165.4 +/- 40.7, respectively (P = 0.356); low-density lipoprotein cholesterol: 245.4 +/- 57.8, 239.8 +/- 48.6, 242.2 +/- 68.6, and 246.4 +/- 49.5, respectively (P = 0.782); and high-density lipoprotein cholesterol: 44.4 +/- 11.2, 41.8 +/- 12.8, 44.6.2 +/- 13.2, and 47 +/- 8.5, respectively (P = 0.431). CONCLUSION:
|
Authors | Alfredo Larrosa-Haro, Cecilia Sáenz-Rivera, Manuel González-Ortiz, Pedro Coello-Ramírez, Gonzalo Vázquez-Camacho |
Journal | Journal of pediatric gastroenterology and nutrition
(J Pediatr Gastroenterol Nutr)
Vol. 36
Issue 1
Pg. 50-3
(Jan 2003)
ISSN: 0277-2116 [Print] United States |
PMID | 12499996
(Publication Type: Journal Article)
|
Chemical References |
- Anticholesteremic Agents
- Triglycerides
- Cholestyramine Resin
- Cholesterol
|
Topics |
- Alagille Syndrome
(blood, complications)
- Anticholesteremic Agents
(therapeutic use)
- Child
- Child, Preschool
- Cholesterol
(blood)
- Cholestyramine Resin
(therapeutic use)
- Dose-Response Relationship, Drug
- Female
- Humans
- Hypercholesterolemia
(blood, complications, drug therapy)
- Male
- Pilot Projects
- Triglycerides
(blood)
|